Proton Magnetic Resonance Spectroscopy: Technique for the Neuroradiologist

Neuroimaging Clinics of North America

Volumn 23, Issue 3, 2013, Pages 381-392

  Cecil, Kim M ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Chemical shift; Localization; Metabolite; Shimming; Spectral dispersion; Suppression

Indexed keywords

4 AMINOBUTYRIC ACID; ACETIC ACID; ACETYL COENZYME A; ACETYLCHOLINE; ALANINE; ASPARTIC ACID; ASPARTOACYLASE; CHOLINE; CITICOLINE; CREATINE; CREATINE PHOSPHATE; GLUCOSE; GLUTAMIC ACID; GLUTAMINE; GLYCEROPHOSPHORYLCHOLINE; INOSITOL; LACTIC ACID; LIPID; N ACETYLASPARTIC ACID; N ACETYLASPARTYLGLUTAMIC ACID; PHOSPHORYLCHOLINE;

AGING; BRAIN ABSCESS; BRAIN DAMAGE; BRAIN DEVELOPMENT; BRAIN TUMOR; CANAVAN DISEASE; CELL MEMBRANE; CELL STRUCTURE; CEREBROVASCULAR ACCIDENT; CLINICAL PROTOCOL; COMPUTER PROGRAM; HUMAN; MULTIPLE SCLEROSIS; NERVE CELL; NERVE CELL LESION; NERVE CELL NECROSIS; NERVE FIBER; NEURORADIOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PELIZAEUS MERZBACHER DISEASE; PHYSICIAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RADIOLOGIST; REVIEW; SIALIC ACID STORAGE DISEASE; SIGNAL NOISE RATIO;

EID: 84881344488     PISSN: 10525149     EISSN: 15579867     Source Type: Journal    
DOI: 10.1016/j.nic.2012.10.003     Document Type: Review

References (49)

1. Drost D.J., Riddle W.R., Clarke G.D. Proton magnetic resonance spectroscopy in the brain: report of AAPM MR Task Group #9. Med Phys 2002, 29(9):2177-2197.
2. Zhu H., Barker P.B. MR spectroscopy and spectroscopic imaging of the brain. Methods Mol Biol 2011, 711:203-226.
3. Di Costanzo A., Trojsi F., Tosetti M., et al. High-field proton MRS of human brain. Eur J Radiol 2003, 48(2):146-153.
4. Tran T., Ross B., Lin A. Magnetic resonance spectroscopy in neurological diagnosis. Neurol Clin 2009, 27(1):21-60. xiii.
5. Srinivasan R., Vigneron D., Sailasuta N., et al. Acomparative study of myo-inositol quantification using LCmodel at 1.5 T and 3.0 T with 3 D 1H proton spectroscopic imaging of the human brain. Magn Reson Imaging 2004, 22(4):523-528.
6. Kreis R. Issues of spectral quality in clinical 1H-magnetic resonance spectroscopy and a gallery of artifacts. NMR Biomed 2004, 17(6):361-381.
7. Posse S., Cuenod C.A., Risinger R., et al. Anomalous transverse relaxation in 1H spectroscopy in human brain at 4 Tesla. Magn Reson Med 1995, 33(2):246-252.
8. Hetherington H.P., Mason G.F., Pan J.W., et al. Evaluation of cerebral gray and white matter metabolite differences by spectroscopic imaging at 4.1T. Magn Reson Med 1994, 32(5):565-571.
9. Barker P.B., Hearshen D.O., Boska M.D. Single-voxel proton MRS of the human brain at 1.5T and 3.0T. Magn Reson Med 2001, 45(5):765-769.
10. Bartha R., Drost D.J., Menon R.S., et al. Comparison of the quantification precision of human short echo time (1)H spectroscopy at 1.5 and 4.0 Tesla. Magn Reson Med 2000, 44(2):185-192.
11. Gruetter R. Automatic, localized invivo adjustment of all first- and second-order shim coils. Magn Reson Med 1993, 29(6):804-811.
12. Haase A., Frahm J., Hanicke W., et al. 1H NMR chemical shift selective (CHESS) imaging. Phys Med Biol 1985, 30(4):341-344.
13. Ogg R.J., Kingsley P.B., Taylor J.S. WET, a T1- and B1-insensitive water-suppression method for invivo localized 1H NMR spectroscopy. JMagn Reson B 1994, 104(1):1-10.
14. Tkac I., Starcuk Z., Choi I.Y., et al. Invivo 1H NMR spectroscopy of rat brain at 1 ms echo time. Magn Reson Med 1999, 41(4):649-656.
15. Duyn J.H., Gillen J., Sobering G., et al. Multisection proton MR spectroscopic imaging of the brain. Radiology 1993, 188(1):277-282.
16. Tran T.K., Vigneron D.B., Sailasuta N., et al. Very selective suppression pulses for clinical MRSI studies of brain and prostate cancer. Magn Reson Med 2000, 43(1):23-33.
17. Osorio J.A., Xu D., Cunningham C.H., et al. Design of cosine modulated very selective suppression pulses for MR spectroscopic imaging at 3T. Magn Reson Med 2009, 61(3):533-540.
18. Pruessmann K.P., Weiger M., Scheidegger M.B., et al. SENSE: sensitivity encoding for fast MRI. Magn Reson Med 1999, 42(5):952-962.
19. Sandgren N., Stoica P., Frigo F.J., et al. Spectral analysis of multichannel MRS data. JMagn Reson 2005, 175(1):79-91.
20. Provencher S.W. Automatic quantitation of localized invivo 1H spectra with LCModel. NMR Biomed 2001, 14(4):260-264.
21. Provencher S.W. Estimation of metabolite concentrations from localized invivo proton NMR spectra. Magn Reson Med 1993, 30(6):672-679.
22. Naressi A., Couturier C., Devos J.M., et al. Java-based graphical user interface for the MRUI quantitation package. MAGMA 2001, 12(2-3):141-152.
23. Naressi A., Couturier C., Castang I., et al. Java-based graphical user interface for MRUI, a software package for quantitation of invivo/medical magnetic resonance spectroscopy signals. Comput Biol Med 2001, 31(4):269-286.
24. Barantin L., Le Pape A., Akoka S. Anew method for absolute quantitation of MRS metabolites. Magn Reson Med 1997, 38(2):179-182.
25. Henriksen O. Invivo quantitation of metabolite concentrations in the brain by means of proton MRS. NMR Biomed 1995, 8(4):139-148.
26. Soher B.J., van Zijl P.C., Duyn J.H., et al. Quantitative proton MR spectroscopic imaging of the human brain. Magn Reson Med 1996, 35(3):356-363.
27. Pouwels P.J., Frahm J. Differential distribution of NAA and NAAG in human brain as determined by quantitative localized proton MRS. NMR Biomed 1997, 10:73-78.
28. Matalon R., Michals K., Sebesta D., et al. Aspartoacylase deficiency and N-acetylaspartic aciduria in patients with Canavan disease. Am J Med Genet 1988, 29(2):463-471.
29. Tallan H.H., Moore S., Stein W.H. N-acetyl-L-aspartic acid in brain. JBiol Chem 1956, 219:257-264.
30. Tallan H.H. Studies on the distribution of N-acetyl-L-aspartic acid in brain. JBiol Chem 1956, 224:41-45.
31. Benuck M., D'Adamo J.A. Acetyl transport mechanisms. Metabolism of N-acetyl-L-aspartic acid in the non-nervous tissues of the rat. Biochim Biophys Acta 1968, 152(3):611-618.
32. D'Adamo A.F., Smith J.C., Woiler C. The occurrence of N-acetylaspartate amidohydrolase (Aminoacylase II) in the developing rat. JNeurochem 1973, 20:1275-1278.
33. Austin S.J., Connelly A., Gadian D.G., et al. Localized 1H NMR spectroscopy in Canavan's disease: a report of two cases. Magn Reson Med 1991, 19:439-445.
34. Brand A., Richter-Landsberg C., Leibfritz D. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 1993, 15(3-5):289-298.
35. Urenjak J., Williams S.R., Gadian D.G., et al. Specific expression of N-acetylaspartate in neurons, oligodendrocyte- type-2 astrocyte progenitors, and immature oligodendrocytes invitro. JNeurochem 1992, 59(1):55-61.
36. Moffett J.R., Tieman S.B., Weinberger D.R., et al. N-Acetylaspartate: a unique neuronal molecule in the central nervous system 2006, Springer, New York.
37. Clark J.F., Doepke A., Filosa J.A., et al. N-acetylaspartate as a reservoir for glutamate. Med Hypotheses 2006, 67(3):506-512.
38. Birken D.L., Oldendorf W.H. N-acetyl-L-aspartic acid: a literature review of a compound prominent in 1H-NMR spectroscopic studies of brain. Neurosci Biobehav Rev 1989, 13(1):23-31.
39. Martin E., Capone A., Schneider J., et al. Absence of N-acetylaspartate in the human brain: impact on neurospectroscopy?. Ann Neurol 2001, 49(4):518-521.
40. Wyss M., Kaddurah-Daouk R. Creatine and creatinine metabolism. Physiol Rev 2000, 80(3):1107-1213.
41. Miller B. Areview of chemical issues in 1H NMR spectroscopy: N-Acetyl-L-aspartate, creatine and choline. NMR Biomed 1991, 4:47-52.
42. Stork C., Renshaw P.F. Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research. Mol Psychiatry 2005, 10(10):900-919.
43. Lee J., Arcinue E., Ross B. Organic osmolytes in the brain of an infant with hypernatremia. NEngl J Med 1994, 331:439-442.
44. Ross B.D. Biochemical considerations in 1H spectroscopy. Glutamate and glutamine; Myo-inositol and related metabolites. NMR Biomed 1991, 4:59-63.
45. Petroff O.A., Pleban L.A., Spencer D.D. Symbiosis between invivo and invitro NMR spectroscopy: the creatine, N-acetylaspartate, glutamate, and GABA content of the epileptic human brain. Magn Reson Imaging 1995, 13(8):1197-1211.
46. Lange T., Dydak U., Roberts T.P., et al. Pitfalls in lactate measurements at 3T. AJNR Am J Neuroradiol 2006, 27(4):895-901.
47. Kreis R., Ernst T., Ross B.D. Development of the human brain: invivo quantification of metabolite and water content with proton magnetic resonance spectroscopy. Magn Reson Med 1993, 30(4):424-437.
48. Pouwels P.J., Frahm J. Regional metabolite concentrations in human brain as determined by quantitative localized proton MRS. Magn Reson Med 1998, 39:53-60.
49. Haga K.K., Khor Y.P., Farrall A., et al. Asystematic review of brain metabolite changes, measured with 1H magnetic resonance spectroscopy, in healthy aging. Neurobiol Aging 2009, 30(3):353-363.